trolamine salicylate has been researched along with Inflammatory Response Syndrome, Systemic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chalasani, V; Cherico, A; Lowther, H; Marco, J; Parameswaran, P; Villgran, V | 1 |
| Gago, R; Vélez-Rivera, J; Vilá, LM; Vilá, S | 1 |
| Lohse, AW; Schramm, C; Sebode, M | 1 |
| Conn, D; Corrigan, F; Flueckiger, P; Mohan, G; Shah, D | 1 |
| Botnaru, V; Corlateanu, A; Covantev, S; Mathioudakis, AG; Siafakas, N | 1 |
| Diamantopoulos, AP; Larsen, AI; Omdal, R | 1 |
| Binard, A; Devauchelle-Pensec, V; Fautrel, B; Flipo, RM; Jousse-Joulin, S; Le Boëdec, M; Le Loët, X; Marhadour, T; Ménard, JF; Saraux, A | 1 |
| Beuers, U; Budenhofer, U; Kremer, AE; Rust, C | 1 |
| Airaghi, L; Catania, A; Cutuli, M; Garofalo, L; Lipton, JM | 1 |
4 review(s) available for trolamine salicylate and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.
Topics: Arthritis; Cachexia; Comorbidity; Disease Progression; Hypertension, Pulmonary; Lung Neoplasms; Metabolic Syndrome; Myocardial Ischemia; Osteoporosis; Prevalence; Pulmonary Disease, Chronic Obstructive; Systemic Inflammatory Response Syndrome | 2016 |
Is it safe to use TNF-α blockers for systemic inflammatory disease in patients with heart failure? Importance of dosage and receptor specificity.
Topics: Animals; Arthritis; Dose-Response Relationship, Drug; Etanercept; Heart Failure; Humans; Immunoglobulin G; Immunosuppressive Agents; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2013 |
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany).
Topics: Alanine Transaminase; Anemia; Antirheumatic Agents; Arthritis; Aspartate Aminotransferases; Cohort Studies; Contraindications; Diagnostic Tests, Routine; Early Diagnosis; Female; Humans; Leukopenia; Liver Diseases; Liver Function Tests; Male; Methotrexate; Renal Insufficiency; Systemic Inflammatory Response Syndrome; Thrombocytopenia | 2013 |
The neuropeptide alpha-MSH in HIV infection and other disorders in humans.
Topics: Acquired Immunodeficiency Syndrome; alpha-MSH; Animals; Arthritis; Humans; Interleukin-1; Myocardial Infarction; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 1998 |
5 other study(ies) available for trolamine salicylate and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
SARS-CoV-2 multisystem inflammatory syndrome in an adult presenting with polyarthritis treated with anakinra.
Topics: Antirheumatic Agents; Arthritis; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Methylprednisolone; Middle Aged; Pandemics; SARS-CoV-2; Systemic Inflammatory Response Syndrome | 2022 |
Severe systemic inflammatory response syndrome immediately after spinal surgery in a patient with axial gout.
Topics: Arthritis; Arthritis, Gouty; Colchicine; Decompression, Surgical; Diagnosis, Differential; Drug Therapy, Combination; Epidural Abscess; Gout Suppressants; Humans; Low Back Pain; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Sacroiliac Joint; Systemic Inflammatory Response Syndrome; Tomography, X-Ray Computed | 2018 |
[Inflammatory diseases with liver and joint involvement. A differential diagnostic challenge].
Topics: Arthritis; Diagnosis, Differential; Hepatitis; Humans; Systemic Inflammatory Response Syndrome | 2013 |
Polyarticular Gout Flare Masquerading as Sepsis.
Topics: Arthritis; Arthritis, Gouty; Blood Chemical Analysis; Diagnosis, Differential; Disease Progression; Follow-Up Studies; Humans; Male; Microscopy, Polarization; Middle Aged; Osteomyelitis; Prednisone; Risk Assessment; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Treatment Outcome; Uric Acid | 2015 |
[A 47-year-old dog breeder with chronic polyarthritis, weight loss and high fever].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Diagnosis, Differential; Disease Progression; Fever of Unknown Origin; Humans; Immunologic Deficiency Syndromes; Isoxazoles; Leflunomide; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Systemic Inflammatory Response Syndrome; Tropheryma; Weight Loss; Whipple Disease | 2008 |